FDA Confirms Pfizer Vaccine Safe, Effective; Approval Expected in Days | Beaufort County Now | Analysis confirms vaccine is 95% effective | daily wire, FDA, pfizer, coronavirus, covid-19, vaccine, safe, effective, approval, december 8, 2020

Coronavirus Disease 2019 (COVID-19)

FDA Confirms Pfizer Vaccine Safe, Effective; Approval Expected in Days

Publisher's Note: This post appears here courtesy of the The Daily Wire. The author of this post is Joseph Curl.

    The Food and Drug Administration (FDA) on Tuesday released a detailed analysis of the COVID-19 vaccine from Pfizer, deeming the two-shot immunization safe and effective.

    The move comes two days ahead of an FDA meeting of the Vaccines and Related Biological Products Advisory Committee, a group of independent experts set to advise the agency on whether to grant the vaccine emergency use authorization (EUA).

    The agency released two separate analyses, one from its own team of scientists and a second from the vaccine's manufacturers, Pfizer Inc. and German partner BioNTech SE. They conclude that the vaccine "met the prescribed success criteria." The vaccine, the FDA said, is "for active immunization for the prevention of COVID-19 caused by SARS-CoV-2 in individuals 16 years of age and older."

    "Safety data from approximately 38,000 participants [greater than or equal to] 16 years of age randomized 1:1 to vaccine or placebo with a median of 2 months of follow up after the second dose suggest a favorable safety profile, with no specific safety concerns identified that would preclude issuance of an EUA," the FDA wrote.

    The FDA's analysis finds "no specific safety concerns identified that would preclude issuance of an EUA." The analysis found that serious reactions were rare but side effects were common, including reactions at the site of injection, headaches and fatigue.

    The analysis also confirmed that the vaccine is 95% effective assessed two doses, 21 days apart, but also said it was 82% effective to prevent COVID-19 after a single dose.

    The vaccine is already in use: A 90-year-old woman in Britain on Tuesday became the first person in the world to receive the Pfizer vaccine.

    Pfizer's is one of three vaccines currently in the works. Biotech firm Moderna on Nov. 30 moved to win emergency use authorization from the FDA for its experimental COVID-19 vaccine.

    Moderna's request came after Pfizer filed their application on Nov. 20. Moderna said its data showed their vaccine was 94.1% effective in its late-stage clinical trial. The Moderna vaccine was developed in conjunction with the Trump administration's Operation Warp Speed.

    A key advantage of Moderna's vaccine is that it does not need sub-zero storage like Pfizer's, which needs to be stored at -94 degrees.

    A third vaccine is also in the pipeline. AstraZeneca and Oxford University on Nov. 23 said their jointly created COVID-19 vaccine has proven to be up to 90% effective, and the makers claim it will be easier to distribute.

    The CDC's Advisory Committee on Immunization Practices (ACIP) on Dec. 2 voted to direct that healthcare workers and residents of long-term care facilities will be the first to get the shots in the initial rollout — once federal regulators authorize use of a vaccine. The recommendation was approved by CDC Director Robert Redfield, but governors will eventually have the final say on who gets the vaccine first.


Latest Op-Ed & Politics

With the U.S. Supreme Court shutting the door this month on future legal action, a state Supreme Court decision will continue to dictate the University of North Carolina’s compliance with public records requests linked to sexual assaults.
Army relieves dozens of soldiers for political reasons
Vice President Mike Pence reportedly called Vice-President Elect Kamala Harris on Thursday to congratulate her on her win.
The Pentagon has reportedly turned down a request from President Donald Trump to have an extravagant sendoff from the White House, nixing the president’s plans to have a military parade at Joint Base Andrews before he departs Washington, D.C.
Many of us are very frustrated with the present political situation in both North Carolina and the Washington, D. C.
Gov. Roy Cooper is again pushing for a multibillion-dollar infrastructure bond, but Republican leaders caution that North Carolina’s still-unsteady economy makes it impossible to tell whether it would be prudent.
Order to release information within 180 days was part of $2.3 trillion COVID-19 relief bill
Clarice Feldman of the American Thinker explores the political calculations linked to President Trump’s second impeachment.


Governor Roy Cooper announced today that the North Carolina Executive Mansion will be illuminated on January 19, 2021, at 5:30 PM in remembrance of the lives lost as in the COVID-19 pandemic.
In her fine opinion piece for the Martin Center, Megan Zogby bemoans the “Quixotic” requirement that North Carolina college and university students take between two and four courses in a language such as Spanish, French, or German.
In this installment, we will discuss the "controversial" Gospel of Judas and how it can be used to decipher cryptic messages made by actors portraying the role of "Judas" in the current political arena..
Frank Main and Fran Spielman write in the Chicago Sun-Times about one consequence of the recent nationwide attack on police.
West Virginia leads the nation in COVID-19 vaccine administration and distribution, even more so than other states that have gained attention for their vaccine rollout strategies, according to federal data from the Centers for Disease Control and Prevention.
Bill Moore looks at the Democrats call for unity
He denounced the assault on the Capitol. But still the Democrats want his head.
Former U.S. House Speaker Newt Gingrich writes at FoxNews.com that the Republican Party is not as likely to fracture as its opponents hope.
Newly sworn in Chief Justice Paul Newby is wasting little time in getting North Carolina’s court system back up and running.


Back to Top